Maharashtra FDA Cancels Cipla Unit’s Drug Sales Licence Over Storage, Regulatory Violations
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sales licences of Cipla Pharma & Life Sciences’ Carrying and Forwarding (C&F) unit in Pune, citing storage deficiencies and regulatory non-compliance.
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sales licences of Cipla Pharma & Life Sciences’ Carrying and Forwarding (C&F) unit in Pune, citing storage deficiencies and regulatory non-compliance. According to an official statement issued by the regulatory body, the cancellation order officially went into effect on August 27, 2026.
The regulatory action follows routine and targeted inspections conducted by state drug inspectors at the facility. During the audits, officials flagged critical operational lapses, including failure to adhere to prescribed storage conditions for pharmaceutical products and non-compliance with provisions governing medicine sales and advertising under the Drugs and Cosmetics Act, 1940. Maharashtra FDA Suspends Blinkit, Zepto, Instamart Licences Over Severe Hygiene And Pest Violations.
Carrying and Forwarding (C&F) facilities serve as vital logistical hubs in the pharmaceutical supply chain, responsible for warehousing, inventory management, and bulk distribution to stockists and retailers. Under Indian drug regulations, maintaining strict temperature controls, batch tracking, and proper storage standards at these centers is mandatory to preserve medicine efficacy and safety before reaching consumers.
The move forms part of an intensified state-wide enforcement drive led by the Maharashtra FDA aimed at ensuring strict adherence to Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) across pharmaceutical supply chains. State regulators emphasized that enforcement against storage and distribution lapses remains non-negotiable to protect public health. Ayub's Food Licence Suspended by FDA: Pics Show Improper Egg Storage, Open Drains in Mumbai’s Famous Late-Night Eatery.
Maharashtra FDA Cancels Drug Sale Licences of Cipla
News Alert! Maharashtra FDA cancels drug sale licences of Cipla Pharma & Life Sciences's Carry and Forwarding unit in Pune: Statement. pic.twitter.com/TX14lXQXTc
— Press Trust of India (@PTI_News) August 28, 2026
Neither Cipla nor its affected C&F unit has issued an official statement regarding immediate plans for appeal, though companies subject to such administrative orders typically retain the right to challenge the cancellation or appeal to higher state health authorities for license restoration upon proving complete compliance.
(The above story first appeared on LatestLY on Aug 28, 2026 07:01 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
